Britain approves Eli Lilly's obesity pill in a European first
British regulators authorised Foundayo, a tablet version of Eli Lilly's obesity and diabetes drug, for use on prescription, which Le Monde describes as the first such approval in Europe. Novo Nordisk has already obtained British approval for its Wegovy tablet, while big pharma is accelerating takeovers of biotech firms ahead of a wave of patent expiries.